Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Apolipoprotein E4 and immune dysfunction in Alzheimer's disease: mechanisms and therapeutic implications.

Created on 19 Oct 2026

Authors

Hao Shi, Yang Zhao, Wei Zhu, Yan-Jiang Wang, Xian-Le Bu

Published in

Trends in neurosciences. Oct 19, 2026. Epub Oct 19, 2026.

Abstract

Emerging evidence suggests that apolipoprotein E4 (APOE4) functions as an organizer of brain-periphery immune crosstalk, coupling maladaptive microglial states with peripheral immune remodeling to establish a self-reinforcing neuroimmune loop that may accelerate the progression of Alzheimer's disease. In the central nervous system, APOE4 pushes microglia away from homeostatic surveillance toward metabolically stressed, inflammatory, and synaptotoxic phenotypes, thereby weakening pathological protein clearance and promoting neurodegeneration. In the periphery, APOE4 primes innate and adaptive immune cells toward a pro-inflammatory state, creating a reservoir that can communicate with the diseased brain and infiltrate it. In addition, APOE4 erodes the separation between central and peripheral immune compartments, enabling bidirectional immune crosstalk that amplifies neuroinflammation and neurodegeneration. In this review, we synthesize evidence for APOE4-driven central and peripheral immune dysregulation; discuss therapeutic opportunities for targeting the APOE4 immune axis; and highlight the need for human-derived, longitudinal, cross-tissue studies to identify causal, stage-specific, and targetable immune nodes for precision intervention.

PMID:
42893889
Bibliographic data and abstract were imported from PubMed on 19 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement